The Central Drugs Standard Control Organisation vide its notification dated 7th April 2020 has decided to grant permission to manufacturers of industrial oxygen to manufacture oxygen for medical use in the situation of COVID-19 pandemic.
In order to facilitate the sufficient supply of oxygen for medical use, the CDSCO has decided that the premises which are having the facility to manufacture industrial oxygen should be granted manufacturing license to manufacture oxygen within 24 hours of receiving the application, fees. Etc as per the Drugs and Cosmetics Act, 1940 and shall submit an undertaking in writing to manufacture the medical oxygen with standards prescribed in Indian Pharmacopeia and labeling requirement.
Click here to read the Notification.
